Counts of positive, neutral, and negative news items. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
The items moving the net sentiment the most, by direction and influence.
Sun Pharma's Organon Financing Deal Draws SBI Into Global Lender Group
Direct news · Medium influence · Long term
Sun Pharma FY26 Revenue Climbs 11.9% to About Rs 58,220 Crore
Direct news · Medium influence · Long term
US Cancer Drug Shortage Creates Generic Supply Window for Sun Pharma and Dr Reddy's
US FDA / USFDA · Medium influence · Short term
Rupee Gains 50 Paise as Cheaper Crude Aids Oil Marketing Stocks
Indian rupee / INR-USD · Low influence · Short term
Sun Pharma Acquires Innovcare Lifesciences for Rs 271 Crore, Expanding Specialty Portfolio
Direct news · Low influence · Short term
Macro, commodity, FX and regulatory forces that moved SUNPHARMA in this range, with the stories behind each.
Sign up free to track SUNPHARMA, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track SUNPHARMA for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Sun Pharma FY26 Revenue Climbs 11.9% to About Rs 58,220 Crore
